Effects of Commonly Used Benzodiazepines on the Fetus, the Neonate, and the Nursing Infant

Psychiatric Services - Tập 53 Số 1 - Trang 39-49 - 2002
Mohammad Iqbal1, Tanveer Sobhan, Thad Ryals
1Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, AL 35594-0017, USA. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bracken MB, Holford TR: Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstetrics and Gynecology 58:336-344, 1981

Shader RI, Greenblatt DJ: Use of benzodiazepines in anxiety disorders. New England Journal of Medicine 328:1398-1405, 1993

Kuhnz W, Nau H: Differences in in vitro binding of diazepam and N-desmethyldiazepam to maternal and fetal plasma proteins at birth: relation to free fatty acid concentration and other parameters. Clinical Pharmacology and Therapeutics 34:220-226, 1983

Mandelli M, Morselli PL, Nordio S, et al: Placental transfer of diazepam and its disposition in the newborn. Clinical Pharmacology and Therapeutics 17:564-572, 1975

Bakke OM, Haram K, Lygre T, et al: Comparison of the placental transfer of thiopental and diazepam in caesarian section. European Journal of Clinical Pharmacology 21:221-227, 1981

Gillberg C: "Floppy infant syndrome" and maternal diazepam. Lancet 2:244, 1977

Mazzi E: Possible neonatal diazepam withdrawal: a case report. American Journal of Obstetrics and Gynecology 129:586-587, 1977

Cree JE, Meyer J, Hailey DM: Diazepam in labour: its metabolism and effect on the clinical condition and thermogenesis of the newborn. British Medical Journal 4:251-255, 1973

Shannon RW, Fraser GP, Aitken RG, et al: Diazepam in preeclamptic toxemia with special reference to its effect on the newborn infant. British Journal of Clinical Practice 26:271-275, 1972

Van der Kleijn E: Protein binding and lipophilic nature of ataractics of the metrobamate and diazapime group. Archives Internationales de Pharmacodynamie et de Therapie 179:225-250, 1969

Allen MD, Greenblatt DJ: Comparative protein binding of diazepam and desmethyldiazepam. Journal of Clinical Pharmacology 21:219-223, 1981

Colburn WA, Gibaldi M: Plasma protein binding of diazepam after a single dose of sodium oleate. Journal of Pharmaceutical Sciences 67:891-892, 1978

Erkkola R, Kanto J, Sellman R: Diazepam in early human pregnancy. Acta Obstetricia et Gynecologica Scandinavica 53:135-138, 1974

Kanto J, Erkkola R: The feto-maternal distribution of diazepam in early human pregnancy. Annales Chirurgiae et Gynaecologiae Fenniae 63:489-491, 1974

Erkkola R, Kangas L, Pekkarinen A: The transfer of diazepam across the placenta during labour. Acta Obstetricia et Gynecologica Scandinavica 52:167-170, 1973

Gamble JAS, Moore J, Lamki H, et al: A study of plasma diazepam levels in mother and infant. British Journal of Obstetrics and Gynaecology 84:588-591, 1977

Kanto J, Erkkola R, Sellman R: Accumulation of diazepam and N-desmethyldiazepam in the fetal blood during labour. Annals of Clinical Research 5:375-379, 1973

Marcucci F, Fanelli R, Frova M, et al: Levels of diazepam in adipose tissue of rats, mice, and man. European Journal of Pharmacology 4:464-466, 1968

Idanpaan-Heikkila JE, Taska RJ, Allen HA, et al: Placental transfer of diazepam 14C in mice, hamsters, and monkeys. Journal of Pharmacology and Experimental Therapeutics 176:752-757, 1971

Aarskog D: Association between maternal intake of diazepam and oral clefts [letter]. Lancet 2:921, 1975

Saxen I: Associations between oral clefts and drugs taken during pregnancy. International Journal of Epidemiology 4:37-44, 1975

Safra MD, Oakley GP: Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2:478-480, 1975

Safra MJ, Oakley GP: An oral cleft teratogen? Cleft Palate Journal 13:198-200, 1976

Saxen I, Saxen L: Association between maternal intake of diazepam and oral clefts. Lancet 2:498, 1975

Rosenberg L, Mitchell AA, Parsells JL, et al: Lack of relation of oral clefts to diazepam use during pregnancy. New England Journal of Medicine 309:1282-1285, 1983

Entman SS, Vaughn WK: Lack of relation of oral clefts to diazepam use in pregnancy [letter]. New England Journal of Medicine 310:1121-1122, 1984

Czeizel A: Diazepam, phenytoin, and aetiology of cleft lip and/or cleft palate [letter]. Lancet 1:810, 1976

Saxen I: Epidemiology of cleft lip and palate: an attempt to rule out chance correlations. British Journal of Preventive and Social Medicine 29:103-110, 1975

Czeizel A, Lendvay A: In utero exposure to benzodiazepines [letter]. Lancet 1:628, 1987

Shino PH, Mills JL: Oral clefts and diazepam use during pregnancy. New England Journal of Medicine 311:919-920, 1984

Czeizel A, Pazsy A, Pusztai J, et al: Aetiological monitor of congenital abnormalities: a case-control surveillance system. Acta Paediatrica Hungarica 24:91-99, 1983

Istavan EJ: Drug-associated congenital abnormalities? [letter] Canadian Medical Association Journal 103:1394, 1970

New Zealand Committee on Drug Reactions: Fourth annual report. New Zealand Medical Journal 70:118-122, 1969

Czeizel A, Szentesi I, Glauber A, et al: Pregnancy outcome and health condition of offspring of self-poisoned pregnant women. Acta Paediatrica Hungarica 25:209-236, 1984

Cerqueira MJ, Olle C, Bellart J, et al: Intoxication by benzodiazepines during pregnancy [letter]. Lancet 1:1341, 1988

Rivas F, Hernandez A, Cantu JM: Acentric craniofacial cleft in a newborn female prenatally exposed to a high dose of diazepam. Teratology 30:179-180, 1984

Laegreid L, Olegard R, Wahlstrom J, et al: Abnormalities in children exposed to benzodiazepines in utero. Lancet 1:108-109, 1987

Olegard R, Sabel KG, Aronson M, et al: Effects on the child of alcoholic abuse during pregnancy. Acta Paediatrica Scandinavica Supplement 275:112-121, 1979

Gerhardsson M, Alfredsson L: In utero exposure to benzodiazepines [letter]. Lancet 1:628, 1987

Winter RM: In utero exposure to benzodiazepines [letter]. Lancet 1:627, 1987

Laegreid L, Hagberg G, Lundberg A: The effect of benzodiazepines on the fetus and the newborn. Neuropediatrics 23:18-23, 1992

Laegreid L, Hagberg G, Lundberg A: Neurodevelopment in late infancy after prenatal exposure to benzodiazepines: a prospective study. Neuropediatrics 23:60-67, 1992

Rothman KJ, Fyler DC, Goldblatt A, et al: Exogenous hormones and other drug exposures of children with congenital heart disease. American Journal of Epidemiology 109:433-439, 1979

Zierler S, Rothman KJ: Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. New England Journal of Medicine 313:347-352, 1985

Tikkanen J, Heinonen OP: Risk factors for conal malformations of the heart. European Journal of Epidemiology 8:48-57, 1992

Tikkanen J, Heinonen OP: Risk factors for ventricular septal defect in Finland. Public Health 105:99-112, 1991

Scanlon JW: Effect of benzodiazepines in neonates [letter]. New England Journal of Medicine 292:649, 1975

Haram K: "Floppy infant syndrome" and maternal diazepam [letter]. Lancet 2:612-613, 1977

Rementeria JL, Bhatt K: Withdrawal symptoms in neonates from intrauterine exposure to diazepine. Journal of Pediatrics 90:123-126, 1977

Backes CR, Cordero L: Withdrawal symptoms in the neonate from presumptive intrauterine exposure to diazepam: report of case. Journal of the American Osteopathic Association 79:584-585, 1980

Speight ANP: Floppy-infant syndrome and maternal diazepam and/or nitrazepam [letter]. Lancet 2:878, 1977

Flowers CE, Rudolph AJ, Desmond MM: Diazepam (valium) as an adjunct in obstetric analgesia. Obstetrics and Gynecology 34:68-81, 1969

Speight ANP: Diazepam in pre-eclamptic toxemia. British Medical Journal 1:1420-1421, 1978

Woods DL, Malan AF: Side effects of maternal diazepam on the newborn infant [letter]. South African Medical Journal 54:636, 1978

Scher J, Hailey DM, Beard RW: The effects of diazepam on the fetus. Journal of Obstetrics and Gynaecology of the British Commonwealth 79:635-638, 1972

Briger M, Homberg R, Insler V: Clinical evaluation of fetal movements. International Journal of Gynecology and Obstetrics 18:377-382, 1980

Schiff D, Chan G, Stern L: Fixed drug combinations and the displacements of bilirubin from albumin. Pediatrics 8:139-141, 1971

Patrick MJ, Tilstone WJ, Reavey P: Diazepam and breast-feeding. Lancet 1:542-543, 1972

Erkkola R, Kanto J: Diazepam and breast-feeding. Lancet 1:1235-1236, 1972

Brandt R: Passage of diazepam and desmethyldiazepam into breast milk. Arzneimittelforschung 26:454-457, 1976

O'Brien TE: Excretion of drugs in human milk. American Journal of Hospital Pharmacy 31:844-845, 1974

Takyi BE: Excretion of drugs in human milk. American Journal of Hospital Pharmacy 38:317-326, 1970

Stirrat GM, Edington P, Berry DJ: Transplacental passage of chlordiazepoxide [letter]. British Medical Journal 2:729, 1974

Wesson DR, Camber S, Harkey M, et al: Diazepam and desmethyldiazepam in breast milk. Journal of Psychoactive Drugs 17:55-56, 1985

Mark PM, Hamel J: Librium for patients in labor. Obstetrics and Gynecology 32:188-194, 1968

Pankaj V, Brain PF: Effects of prenatal exposure to benzodiazepine-related drugs on early development and adult social behavior in Swiss mice: I. agonists. General Pharmacology 22:33-41, 1991

Milkovich L, Van den Berg BJ: Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. New England Journal of Medicine 291:1268-1271, 1974

Crombie DL, Pinsent RJ, Fleming DM, et al: Fetal effects of tranquilizers in pregnancy. New England Journal of Medicine 293:198-199, 1975

Kullander S, Kallen B: A prospective study of drugs and pregnancy: I. psychopharmaca. Acta Obstetricia Gynecologica Scandinavica 55:25-33, 1976

Hartz SC, Heinonen OP, Shapiro S, et al: Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. New England Journal of Medicine 292:726-728, 1975

Czeizel A: Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reproductive Toxicology 1:183-188, 1988

Decaneq Jr HG, Bosco JR, Townsend EH: Chlordiazepoxide in labor: its effect on the newborn infant. Journal of Pediatrics 67:836-840, 1965

Bitnun S: Possible effects of chlordiazepoxide on the foetus. Canadian Medical Association Journal 100:351, 1969

Athinarayanan P, Peirog SH, Nigam SK, et al: Chlordiazepoxide withdrawal in the neonate. American Journal of Obstetrics and Gynecology 124:212-213, 1976

Catz CS, Giocoia GP: Drugs and breast milk. Pediatric Clinics of North America 19:151-166, 1972

Fisher JB, Edgren BE, Mammel MC, et al: Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstetrics and Gynecology 66:34S-35S, 1985

Czeizel AE, Bod M, Halasz P: Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. European Journal of Epidemiology 8:122-127, 1992

Haeusler MC, Hoellwarth ME, Holzer P: Paralytic ileus in a fetus-neonate after maternal intake of benzodiazepine. Prenatal Diagnosis 15:1165-1177, 1995

Kriel RL, Cloyd J: Clonazepam and pregnancy [letter]. Annals of Neurology 11:544, 1982

Calabrese JR, Gulledge AD: Carbamazepine, clonazepam use during pregnancy [letter]. Psychosomatics 27:464, 1986

Eskazan E, Aslan S: Antiepileptic therapy and teratogenicity in Turkey. International Journal of Clinical Pharmacology, Therapy, and Toxicology 30:261-264, 1992

Kaneko S, Koichi O, Yutaka F, et al: Teratogenicity of antiepileptic drugs: analysis of possible risk factor. Epilepsia 29:459-467, 1988

Dansky L, Andermann E, Sherwin AL, et al: Maternal epilepsy and congenital malformations: a prospective study with monitoring of plasma anticonvulsant levels during pregnancy [letter]. Neurology 3:15, 1980

Johnson KA, Jones KL, Chambers CD, et al: Pregnancy outcome in women exposed to non-valium benzodiazepines [letter]. Reproductive Toxicology 9:585, 1995

Johnson KA, Jones KL, Chambers CD, et al: Pregnancy outcome in women exposed to non-Valium benzodiazepines [letter]. Teratology 51:170, 1995

McElhatton PR: The effects of benzodiazepine use during pregnancy and lactation. Reproductive Toxicology 8:461-475, 1994

Malone FD, D'Alton ME: Drugs in pregnancy: anticonvulsants. Seminars in Perinatology 21:114-123, 1997

McBride RJ, Dundee JW, Moore J, et al: A study of the plasma concentrations of lorazepam in mother and infant. British Journal of Anaesthesia 51:971-978, 1979

Kanto J, Aaltonen L, Linkka P, et al: Transfer of lorazepam and its conjugate across the human placenta. Acta Pharmacologica et Toxicologica 47:130-134, 1980

Whitelaw AGL, Cummings AJ, McFadyen IR: Effect of maternal lorazepam on the neonate. British Medical Journal 282:1106-1108, 1981

Athinarayanan P, Peirog SH, Nigam SK, et al: Chlordiazepoxide withdrawal in the neonate. American Journal of Obstetrics and Gynecology 124:212-213, 1976

Godet PF, Damato T, Dalery J, et al: Benzodiazepines in pregnancy: analysis of 187 exposed infants drawn from a population-based birth defects registry. Reproductive Toxicology 9:585, 1995

Herd B, Clarke F: Complete heart block after flumazenil. Human and Experimental Toxicology 10:289, 1991

McAuley DM, O'Neill MP, Moore J, et al: Lorazepam premedication for labour. British Journal of Obstetrics and Gynaecology 89:149-154, 1982

Sanchis A, Rosique D, Catala J: Adverse effects of maternal lorazepam on neonates. DICP Annals of Pharmacotherapy 25:1137-1138, 1991

Erkkola R, Kero P, Kanto J, et al: Severe abuse of psychotropic drugs during pregnancy with good perinatal outcome. Annals of Clinical Research 15:88-91, 1983

Majer RV, Green PJ: Neonatal afibrinogenaemia due to sodium valproate. Lancet 2:740-741, 1987

Summerfield RJ, Nielsen MS: Excretion of lorazepam into breast milk. British Journal of Anaesthesia 57:1042-1043, 1985

Johnstone MJ: The effect of lorazepam on neonatal feeding behavior at term. Pharmatherapeutica 3:259-262, 1982

Christensen HD, Gonzalez CL, Rayburn WF: Impact of prenatal alprazolam (Xanax N) on social play in inbred mice. Teratology 51:181-182, 1995

Gonzalez C, Smith R, Christensen HD, et al: Prenatal alprazolam induces subtle impairments in hind limb balance and dexterity in C57BL/6 mice [abstract]. Teratology 49:390, 1994

Garzone PD, Kroboth PD: Pharmacokinetics of the newer benzodiazepines. Clinical Pharmacokinetics 16:337-364, 1989

St Clair SM, Schirmer RG: First trimester exposure to alprazolam. Obstetrics and Gynecology 80:843-846, 1992

Ornay A, Arnon J, Shechtman S, et al: Is benzodiazepine use during pregnancy really teratogenic? Reproductive Toxicology 12:511-515, 1998

Schick-Boschetto B, Zuber C: Alprazolam exposure during early human pregnancy [abstract]. Teratology 45:460, 1992

Barry WS, St Clair SM: Exposure to benzodiazepines in utero. Lancet 1:1436-1437, 1987

Vendittelli F, Alain J, Nouaille Y, et al: A case of lipomeningocele reported with fluoxetine (and alprazolam, vitamins B1 and B6, heptaminol) prescribed during pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 58:85-86, 1995

Shader RI: Is there anything new on the use of psychotropic drugs during pregnancy? Journal of Clinical Psychopharmacology 14:438, 1994

Oo CY, Kuhn RJ, Desai N, et al: Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. British Journal of Clinical Pharmacology 40:231-236, 1995

Anderson PO, McGuire GG: Neonatal alprazolam withdrawal: possible effects of breast feeding [letter]. DICP Annals of Pharmacotherapy 23:614, 1989

Ito S, Blajchman A, Stephenson M, et al: Prospective follow-up of adverse reactions in breastfed infants exposed to maternal medication. American Journal of Obstetrics and Gynecology 168:1393-1399, 1993